Keyword: bigpharma
-
The Department of Health and Human Services released a 400-page report today titled "Treatment for Pediatric Gender Dysphoria." The report only addresses treatment for those 18 and under and appears to follow the UK's Cass Review in recommending more therapy for children and less use of medical intervention, such as puberty blockers and hormones.The 409-page Health and Human Services report questions standards for the treatment of transgender youth issued by the World Professional Association for Transgender Health and is likely to be used to bolster the government’s abrupt shift in how to care for a subset of the population that...
-
As Planned Parenthood has expanded its so-called “gender-affirming care” over the past decade, detransitioners who obtained hormones from the corporation have publicly repudiated Planned Parenthood’s dangerous transgender practices. Planned Parenthood disproportionately targets young people aged 18-22 with its so-called “gender affirming care.” As can be observed by reading stories of detransitioners, most describe having been vulnerable and even struggling with mental illness when they sought “treatment” for gender dysphoria from Planned Parenthood. The cross-sex hormones left some of them with permanent issues. Though the number of people negatively affected by Planned Parenthood’s “gender affirming care” will never be known, some...
-
The Texas Senate has passed a bill to allow citizens to sue anyone who manufactures, mails, or distributes abortion pills in Texas for $100,000. Senate Bill 2880 would help expand the Texas Heartbeat Act, which was passed in 2021. Under the Texas Heartbeat Act, abortions cannot be committed after a preborn child’s heartbeat is detected, which is typically around 21 days gestation. The law is unique because rather than enacting criminal penalties, it allowed individual citizens to file lawsuits against anyone who violates the law. Last December, New York abortionist Margaret Carpenter was caught shipping abortion pills to women in...
-
One in ten patients experience a “serious adverse event” after taking the abortion pill, according to a study released Monday by the Ethics and Public Policy Center (EPPC), a conservative think tank and advocacy group. The study found that 10.93% of women experienced sepsis, infection, hemorrhaging, or another serious adverse event within 45 days after a mifepristone abortion. The real-world rate of serious adverse events after mifepristone abortions is at least 22 times as high as the summary figure of “less than 0.5%” in clinical trials reported on the drug label, according to the study. Mifepristone, when used together with...
-
New study reveals an adverse event rate 22 times higher than the FDA-approved drug label reports. (Washington, DC): In a first-of-its-kind study, “The Abortion Pill Harms Women”, the Ethics and Public Policy Center (EPPC) reveals that serious adverse events from mifepristone are approximately 22 times more frequent than the Food and Drug Administration (FDA) currently recognizes. The study shows that, following a mifepristone abortion, 10.93 percent of women experience sepsis, infection, hemorrhaging, or another serious or life-threatening adverse event. That is, over one in ten patients experience at least one serious adverse event. The study, authored by Jamie Bryan Hall,...
-
As Big Abortion offloads its medical responsibility onto women who purchase the abortion pill, those women are expected to function as their own doctor, nurse, and pathologist in so-called “self-managed” mail-order abortions. Additionally, in an apparent deceptive scheme to hide adverse abortion pill outcomes, abortion profiteers also advise women experiencing serious complications to present to the emergency room (ER) and lie about the cause of those complications. This, of course, helps no one but the industry itself. When things go wrong, women do not end up at the door of the prescriber, who is clear of any responsibility for the...
-
Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder (ADHD) were significantly more likely to develop cardiomyopathy (weakened heart muscle) compared with those who were not prescribed stimulants, in a study presented at the American College of Cardiology’s Annual Scientific Session. The study found that people prescribed stimulants such as Adderall and Ritalin were 17% more likely to have cardiomyopathy at one year and 57% more likely to have cardiomyopathy at eight years compared with those who were not taking these medications. Cardiomyopathy involves structural changes in the heart muscle that weaken its pumping ability. It can cause a...
-
U.S. Food and Drug Administration (FDA) Commissioner Martin Makary announced a new policy directive limiting employees of companies the agency regulates, such as pharmaceutical companies, from serving as official members of FDA advisory committees. “While the FDA should be partnering with industry to ensure a user-friendly review process, the scientific evaluation of new products should be independent,” Makary said. “Industry employees are welcome to attend FDA advisory committee meetings, along with the rest of the American public, but having industry employees serve as official members of FDA advisory committee members represents a cozy relationship that is concerning to many Americans,”...
-
Democrats on the House Judiciary Committee grilled whistleblower Dr. Eithan Haim this week over his criticism of transgender medical treatments, months after the Biden Justice Department dropped criminal charges against him. During a Wednesday hearing titled "Ending Lawfare Against Whistleblowers Who Protect Children," Haim defended his decision to leak documents to the media, revealing that Texas Children’s Hospital in Houston performed transgender medical procedures on minors through May 2023. "I wouldn't want this to be done to anyone, not even liberals, even if they're the craziest communists ever," Haim said during the hearing. "There's no one in this country who...
-
Pharmaceutical imports were initially exempt from Trump’s first set of reciprocal tariffs last week but his administration has since indicated that levies on the sector are coming. Global drugmakers’ stocks dropped across the board on Wednesday after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply chain across the world, and as his country-specific reciprocal tariffs took effect, leading to more pain in global markets. Pharmaceutical imports were initially exempt from Trump’s first set of reciprocal tariffs last week but his administration has since indicated that levies on the sector, which in...
-
US President Donald Trump says he will soon announce "major" tariffs on imported pharmaceuticals, a move that could end decades of low-cost global trade in medicines. For years, most countries, including the US, have imposed few or no tariffs on finished drugs, thanks in part to a 1995 World Trade Organisation (WTO) agreement aimed at keeping medicines affordable. This shift comes after Trump introduced a blanket 10% tariff on other imports last week, as part of a broader effort to bring manufacturing back to the US. His new "reciprocal" tariffs - including a duty of 104% on goods arriving from...
-
Despite multiple Freedom of Information Act (FOIA) requests seeking clarity on DNA contamination and plasmid DNA in Pfizer and Moderna’s COVID-19 vaccines, the official full genetic sequence of the plasmid DNA backbone—and the results of safety studies evaluating its risks—remain undisclosed. This new FOIA request, prompted by Dr. Richard Bartlett, aims to address these gaps and demand accountability. There is a proposed FOIA at the bottom of this article. Background: What We Already Know Several FOIA requests have previously sought information regarding DNA contamination in mRNA vaccines. For example: MHRA FOIA Response: The UK’s Medicines and Healthcare Products Regulatory Agency...
-
Two bills that would strengthen protections for transgender people and gender-affirming care won preliminary approval in the Colorado House on Friday. They come as transgender rights and protections are put on shaky ground at the federal level under the Trump administration, which has issued orders to recognize only two unchangeable genders, stop offering non-binary passport gender markers, and attempts to stop funding care for transgender minors.
-
Democrats in CO are now pushing bill HB25-1312 which would take “misgendering” & “deadnaming” into account during custody hearings. Colorado father gagged for refusing to let his 13-year old son be sterilized. For that, Colorado courts stripped him of his parental rights - banning him from even talking to his child about gender, medical treatment, or the court case. "I haven't slept well forever... I'm afraid for my child."
-
A new peer-reviewed study links the mRNA COVID-19 vaccines to long-term changes in genetic structures that can provoke an inflammatory response, and lead to the onset of cancer and autoimmune disorders. The study by 19 German scientists was published last week in Molecular Systems Biology. The researchers said their findings may account for “post vaccination inflammatory diseases which occur in a small number of vaccinated individuals.”
-
Pharma stocks tumbled today after Peter Marks, M.D., Ph.D., director of the agency within the U.S. Food and Drug Administration (FDA) responsible for authorizing vaccines, resigned under pressure from his new boss, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. "If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy," an HHS official said in a statement. Shares of Moderna, BioNTech, Novavax and Pfizer declined 11%, 7%, 6% and 2%, respectively, on the news, Fast...
-
Dr. Peter Marks, the agency’s top vaccine official and a key figure in the first Trump administration’s Operation Warp Speed, has been ousted from his post. Dr. Peter Marks is an American hematologist-oncologist who has served as the director of the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) since 2016. As CBER director, Marks was responsible for reviewing and providing advice during product development, evaluating applications, and making approval decisions based on safety and effectiveness data. He oversaw the FDA’s vaccine programs and played a pivotal part in the rapid development and...
-
More empathy—and investment—is needed to address vaccine-related injuries, says Harvard T.H. Chan School of Public Health’s Kizzmekia Corbett-Helaire. Corbett-Helaire, assistant professor of immunology and infectious diseases, was one of the developers of the COVID-19 vaccine. She also talked about her June 11 opinion piece in STAT, in which she wrote that she believes more empathy is needed for people who report experiencing long-term side effects from the COVID-19 vaccine. “People who speak out about how they feel after getting a vaccine should not be dismissed or assumed to be anti-vaxxers,” she wrote. “For starters, they deserve empathy from their doctors...
-
Recent studies have illuminated the emergence of vaccine-induced acute pancreatitis, notably associated with COVID-19 vaccinations, presenting diverse mechanisms ranging from direct viral-mediated injury to autoimmune reactions. Understanding this link is pivotal for public health, yet challenges persist in identifying and managing cases post-vaccination.
-
https://x.com/TonySeruga/status/1890926738458517785Tony Seruga@TonySeruga·Feb 15I warned this was going to happen and they are on track.Labcorp has ramped up FAKE fraudulent Bird Flu tests in the U.S.Once again, we are literally using PCR process to create pandemics on demand.PCR is not a diagnostic test, it is a DNA amplification PROCESS. Nothing more.
|
|
|